NDC 11822-0046 – Guaifenesin and Pseudoephedrine HCl

Guaifenesin 600 mg/1; Pseudoephedrine Hydrochloride 60 mg/1 · Tablet, Extended Release · Oral

Human Otc Drug

Product NDC11822-0046

Product details

Brand name
Guaifenesin and Pseudoephedrine HCl
Generic name
Guaifenesin and Pseudoephedrine HCL
Labeler
Rite Aid Corporation
Dosage form
Tablet, Extended Release
Route
Oral
Marketing category
ANDA · ANDA208369
Marketed since
February 1, 2022
Listing expires
December 31, 2026
Pharmacologic class
Expectorant; alpha-Adrenergic Agonist

Active ingredients

Uses, dosage, side effects and warnings for Guaifenesin and Pseudoephedrine HCl →

Package NDC codes (2)

Package NDCDescriptionSince
11822-0046-11 BLISTER PACK in 1 CARTON (11822-0046-1) / 18 TABLET, EXTENDED RELEASE in 1 BLISTER PACKFeb 1, 2022
11822-0046-22 BLISTER PACK in 1 CARTON (11822-0046-2) / 18 TABLET, EXTENDED RELEASE in 1 BLISTER PACKFeb 1, 2022

Other Guaifenesin and Pseudoephedrine HCl products